Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

916 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M. Magi-Galluzzi C, et al. Among authors: montironi r. Lab Invest. 1997 Jan;76(1):37-51. Lab Invest. 1997. PMID: 9010448
Current and proposed biologic markers in prostate cancer.
Bostwick DG, Montironi R, Nogle R, Pretlow T, Miller G, Wheeler T, Epstein J, Sakr W. Bostwick DG, et al. Among authors: montironi r. J Cell Biochem Suppl. 1992;16H:65-7. doi: 10.1002/jcb.240501214. J Cell Biochem Suppl. 1992. PMID: 1289675 No abstract available.
Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma.
Magi-Galluzzi C, Montironi R, Prete E, Kwan PW, Delellis RA. Magi-Galluzzi C, et al. Among authors: montironi r. Anticancer Res. 1996 Sep-Oct;16(5A):2931-6. Anticancer Res. 1996. PMID: 8917409
Mitogen-activated protein kinases and apoptosis in PIN.
Magi-Galluzzi C, Montironi R, Cangi MG, Wishnow K, Loda M. Magi-Galluzzi C, et al. Among authors: montironi r. Virchows Arch. 1998 May;432(5):407-13. doi: 10.1007/s004280050184. Virchows Arch. 1998. PMID: 9645439
p63 is a prostate basal cell marker and is required for prostate development.
Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, Yang A, Montironi R, McKeon F, Loda M. Signoretti S, et al. Among authors: montironi r. Am J Pathol. 2000 Dec;157(6):1769-75. doi: 10.1016/S0002-9440(10)64814-6. Am J Pathol. 2000. PMID: 11106548 Free PMC article.
Her-2-neu expression and progression toward androgen independence in human prostate cancer.
Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Signoretti S, et al. Among authors: montironi r. J Natl Cancer Inst. 2000 Dec 6;92(23):1918-25. doi: 10.1093/jnci/92.23.1918. J Natl Cancer Inst. 2000. PMID: 11106683
Cellular and molecular pathology of prostate cancer precursors.
Foster CS, Bostwick DG, Bonkhoff H, Damber JE, van der Kwast T, Montironi R, Sakr WA. Foster CS, et al. Among authors: montironi r. Scand J Urol Nephrol Suppl. 2000;(205):19-43. doi: 10.1080/003655900750169284. Scand J Urol Nephrol Suppl. 2000. PMID: 11144897 Review.
Molecular changes associated with prostate cancer development.
Ruijter E, Montironi R, van de Kaa C, Schalken J. Ruijter E, et al. Among authors: montironi r. Anal Quant Cytol Histol. 2001 Feb;23(1):67-88. Anal Quant Cytol Histol. 2001. PMID: 11233745 Review.
Frequent FGFR3 mutations in urothelial papilloma.
van Rhijn BW, Montironi R, Zwarthoff EC, Jöbsis AC, van der Kwast TH. van Rhijn BW, et al. Among authors: montironi r. J Pathol. 2002 Oct;198(2):245-51. doi: 10.1002/path.1202. J Pathol. 2002. PMID: 12237885
Apolipoprotein E expression in localized prostate cancers.
Venanzoni MC, Giunta S, Muraro GB, Storari L, Crescini C, Mazzucchelli R, Montironi R, Seth A. Venanzoni MC, et al. Among authors: montironi r. Int J Oncol. 2003 Apr;22(4):779-86. Int J Oncol. 2003. PMID: 12632068
916 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page